GO:0032181 dinucleotide repeat insertion binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032181 dinucleotide repeat insertion binding describes a molecular function: binding to double-stranded DNA containing a dinucleotide repeat insertion or a deletion that leaves unpaired dinucleotide repeats.
• Dinucleotide repeats are short tandem repeats whose length changes can create unpaired loops that are recognized by mismatch repair and other DNA-binding proteins.
• MutSbeta (MSH2/MSH3) is a key dinucleotide-loop-binding complex and exceeds MutSalpha in repairing dinucleotide loops, linking this function to microsatellite instability.
• Expanded repeats, including CCTG in myotonic dystrophy type 2, can arise from insertion events such as AluSx element insertion and confer dependence on WRN helicase in microsatellite-unstable cancers [1,8].
• Studying this function requires assays that detect protein binding to defined repeat-containing DNA, such as EMSA, ChIP, and CRISPR-engineered repeat knock-in models.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell models allow causal testing of candidate repeat-binding proteins in disease-relevant backgrounds [1,5].
Description
GO:0032181 dinucleotide repeat insertion binding is a molecular function term that defines the binding of a protein or protein complex to a double-stranded DNA region containing a dinucleotide repeat insertion or a deletion that results in unpaired dinucleotide repeats. Dinucleotide repeats are abundant in eukaryotic genomes, and changes in their length can generate unpaired loops that are recognized by DNA-binding and repair factors. This function is therefore central to how cells detect and process repetitive DNA structures. The term matters because dinucleotide repeat instability is a hallmark of mismatch repair deficiency and microsatellite-unstable cancers, and because repeat expansions underlie several neuromuscular and neurodegenerative disorders [1,5]. Proteins that bind dinucleotide repeat insertions help initiate repair, modulate transcription, or influence replication fork progression, making this function a focal point for mechanistic and translational research [1,5]. Understanding which proteins bind these structures, and how binding is regulated, can reveal therapeutic vulnerabilities in cancers that depend on repeat-processing pathways.
dinucleotide repeat insertion binding At A Glance
| GO ID | GO:0032181 |
|---|---|
| GO term | dinucleotide repeat insertion binding |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Major function | Binding to double-stranded DNA containing a dinucleotide repeat insertion or unpaired dinucleotide repeats |
| Substrate | Double-stranded DNA with inserted or unpaired dinucleotide repeats |
| Representative binder | MutSbeta (MSH2/MSH3) complex |
| Disease link | Microsatellite instability, repeat expansion disorders, and cancers with WRN dependence [1,5,8] |
| Research relevance | Mechanistic studies of mismatch repair, repeat instability, and CRISPR-engineered repeat models [1,5] |
What Is GO:0032181?
In plain terms, GO:0032181 describes the ability of a protein to physically attach to a double-stranded DNA molecule that contains an inserted dinucleotide repeat, or a deletion that leaves unpaired dinucleotide repeats. The binding event occurs on DNA, not on RNA or protein, and it is specific for repeat-containing or loop-containing DNA rather than generic double-stranded DNA. This function is often measured by incubating a candidate protein with defined repeat-containing DNA substrates and detecting stable complexes.
Why Is dinucleotide repeat insertion binding Important in Cell Biology?
Dinucleotide repeat insertion binding is important because it sits at the interface of DNA repair, genome stability, and human disease. Proteins that recognize unpaired dinucleotide repeats help cells detect and correct replication errors, and when this function is impaired, microsatellite instability can drive cancer. In addition, expanded repeats such as the CCTG repeat in myotonic dystrophy type 2 can originate from insertion events and create structures that alter gene expression and cellular physiology. Recent work shows that repeat expansions can confer dependence on WRN helicase in microsatellite-unstable cancers, highlighting how repeat-binding and repeat-processing pathways can be exploited therapeutically. For researchers, this term provides a precise functional annotation for proteins that interact with repetitive DNA, enabling better interpretation of CRISPR screens, ChIP data, and repair assays [1,5].
• Defines a specific DNA-binding activity toward dinucleotide repeat insertions and unpaired repeats.
• Links mismatch repair complexes, especially MutSbeta, to dinucleotide loop recognition.
• Provides a mechanistic explanation for microsatellite instability in cancers.
• Connects repeat insertion events to repeat expansion disorders such as myotonic dystrophy type 2.
• Supports research on WRN-dependent vulnerabilities in microsatellite-unstable cancers.
• Enables functional annotation of proteins identified in CRISPR screens for repeat instability.
• Guides design of DNA substrates for binding assays and structural studies.
• Helps interpret ChIP-seq and related datasets that map proteins to repetitive genomic regions.
• Informs development of biomarkers for mismatch repair deficiency.
• Provides a framework for testing candidate repeat-binding proteins with CRISPR models [1,5].
Molecular Mechanism of dinucleotide repeat insertion binding
Recognition of unpaired dinucleotide repeats
In simple terms: The protein must first find and physically contact the unusual DNA structure created by an inserted or unpaired dinucleotide repeat.
Dinucleotide repeat insertions or deletions can produce unpaired repeats that distort the double helix and create a substrate for specific DNA-binding proteins. MutSbeta (MSH2/MSH3) is a well-characterized complex that binds such dinucleotide loops and exceeds MutSalpha in dinucleotide loop repair, indicating that recognition of unpaired dinucleotide repeats is a distinct molecular function. This binding step is the first committed event in pathways that process repeat-containing DNA.
Substrate specificity and DNA conformation
In simple terms: The binding is not random; it depends on the exact shape and sequence of the repeat-containing DNA.
The substrate for GO:0032181 is double-stranded DNA containing a dinucleotide repeat insertion or a deletion that leaves unpaired dinucleotide repeats. Structural studies of repetitive DNA show that dinucleotide repeats can adopt alternating conformations, and such conformational features may influence protein recognition. Specificity for dinucleotide loops distinguishes this function from general double-stranded DNA binding and from binding to other repeat types.
Complex assembly and cofactor requirements
In simple terms: Binding often involves a multi-protein complex rather than a single protein, and cofactors can modulate the interaction.
MutSbeta is a heterodimer of MSH2 and MSH3, and its ability to bind dinucleotide loops is central to its role in mismatch repair. Other repeat-binding activities may involve additional cofactors, including nucleotide cofactors such as NADPH in unrelated repeat-domain proteins, although these are not directly implicated in GO:0032181. The assembly of the appropriate complex is therefore a key determinant of dinucleotide repeat insertion binding.
Downstream signaling and repair commitment
In simple terms: Once bound, the protein recruits other factors that decide whether the repeat is repaired, tolerated, or processed further.
Binding of MutSbeta to dinucleotide loops initiates mismatch repair signaling that can lead to excision and resynthesis of the repeat-containing strand. In microsatellite-unstable cancers, repeat expansions can create structures that confer dependence on WRN helicase, linking repeat processing to replication stress responses. Thus, dinucleotide repeat insertion binding is not an isolated event but a trigger for downstream genome maintenance pathways [1,5].
Regulation by repeat length and genomic context
In simple terms: The strength and outcome of binding can change with repeat length and where the repeat sits in the genome.
The CCTG repeat responsible for myotonic dystrophy type 2 originated from an AluSx element insertion into an early primate genome, illustrating how genomic context and insertion events can create expandable dinucleotide repeats. Repeat length and flanking sequence can influence the efficiency of protein binding and subsequent processing [5,8]. These features make dinucleotide repeat insertion binding sensitive to both sequence and chromatin environment [1,5].
Key Genes Involved in GO:0032181 dinucleotide repeat insertion binding
The following genes and proteins are directly or indirectly implicated in dinucleotide repeat insertion binding and its downstream biology, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MSH2 | Core component of MutSbeta and MutSalpha complexes that bind dinucleotide loops | Central to mismatch repair and microsatellite instability studies |
| MSH3 | Partner of MSH2 in MutSbeta, which exceeds MutSalpha in dinucleotide loop repair | Key determinant of dinucleotide repeat binding specificity |
| MSH6 | Partner of MSH2 in MutSalpha, with lower activity on dinucleotide loops | Comparative studies of repeat recognition |
| WRN | Helicase required for survival of microsatellite-unstable cancers with repeat expansions | Therapeutic target in repeat-expansion cancers |
| ELN | Elastin gene containing dinucleotide repeats and structural motifs | Model for studying repeat-containing gene structure |
| NCF1 | Encodes p67PHOX, which contains tetratricopeptide repeats and binds NADPH | Example of repeat-domain binding outside DNA context |
| MOS1 | Transposase that captures target DNA during transposition | Model for studying DNA target capture |
| SB100X | Sleeping Beauty transposase used for gene therapy with prolonged expression | Tool for genomic insertion and repeat modeling |
| DMPK | Gene whose CCTG expansion causes myotonic dystrophy type 2 | Disease model for repeat expansion |
| CNBP | Gene containing the CCTG repeat expanded in myotonic dystrophy type 2 | Direct link between repeat insertion and disease |
| POLB | Polymerase involved in repair synthesis at repeat sites | Potential modifier of repeat stability |
| LIG1 | Ligase involved in mismatch repair downstream of MutSbeta | Candidate for CRISPR knockout studies |
| PCNA | Proliferating cell nuclear antigen that coordinates mismatch repair | Relevant to replication-coupled repeat processing |
| RPA1 | Single-stranded DNA-binding protein that assists repair | Potential cofactor in repeat processing |
| EXO1 | Exonuclease that participates in mismatch repair excision | Candidate for functional studies |
| MLH1 | Mismatch repair protein that partners with PMS2 | Core mismatch repair gene for knockout models |
| PMS2 | Mismatch repair endonuclease that acts after MutS complexes | Relevant to repeat repair outcomes |
How Is dinucleotide repeat insertion binding Regulated?
Dinucleotide repeat insertion binding is regulated at multiple levels. The abundance and stoichiometry of MutSbeta subunits MSH2 and MSH3 determine how efficiently dinucleotide loops are recognized, and MutSbeta exceeds MutSalpha in dinucleotide loop repair. Repeat length and genomic context, such as insertion into an AluSx element, can create expandable CCTG repeats that alter the substrate landscape. In microsatellite-unstable cancers, repeat expansions confer dependence on WRN helicase, indicating that replication stress and helicase activity modulate the consequences of repeat binding. These layers of regulation mean that the functional output of dinucleotide repeat insertion binding depends on both the DNA substrate and the cellular repair environment [1,5,8].
dinucleotide repeat insertion binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSH3 | Microsatellite instability and mismatch repair deficiency | MSH3 knockout cell line with dinucleotide repeat reporter |
| MSH2 | Lynch syndrome and mismatch repair cancers | MSH2 point-mutation knock-in cells |
| WRN | Microsatellite-unstable cancers with repeat expansions | WRN knockout in repeat-expansion cancer cells |
| CNBP | Myotonic dystrophy type 2 | CCTG repeat knock-in model |
| ELN | Elastin gene structure and repeat biology | ELN repeat-containing reporter cells |
Microsatellite instability and cancer
Dinucleotide repeat insertion binding is directly relevant to microsatellite instability because MutSbeta recognizes dinucleotide loops and exceeds MutSalpha in dinucleotide loop repair. When this function is compromised, dinucleotide repeats can become unstable, contributing to the mutator phenotype observed in mismatch repair-deficient cancers. Recent work shows that repeat expansions in microsatellite-unstable cancers confer dependence on WRN helicase, revealing a therapeutic vulnerability linked to repeat processing.
Myotonic dystrophy type 2 and repeat expansion disorders
The unstable CCTG repeat responsible for myotonic dystrophy type 2 originated from an AluSx element insertion into an early primate genome, demonstrating how insertion events can seed pathogenic repeats. Proteins that bind dinucleotide repeat insertions may influence the stability and expansion of such repeats [5,8]. This connection places GO:0032181 in the broader context of repeat expansion diseases.
Therapeutic implications of repeat-binding pathways
Because repeat expansions can create dependencies on specific helicases such as WRN, understanding dinucleotide repeat insertion binding may guide the development of targeted therapies for microsatellite-unstable cancers. Assays that measure binding to defined repeat substrates can help prioritize candidate targets for drug discovery. This translational angle makes the term relevant beyond basic DNA repair biology [1,5].
From dinucleotide repeat insertion binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MSH3 alter dinucleotide repeat binding? | MSH3 knockout cell line |
| Does a specific MSH2 mutation impair dinucleotide loop recognition? | MSH2 point-mutation knock-in |
| Can a candidate protein bind dinucleotide repeat insertions in vivo? | Tagged knock-in of the candidate gene |
| Does overexpression of a repeat-binding protein destabilize repeats? | Overexpression cell model |
| Is WRN required for survival of repeat-expanded cancer cells? | WRN knockout in microsatellite-unstable background |
| Does the CCTG repeat insertion alter gene expression? | CCTG repeat knock-in reporter |
How to Study the dinucleotide repeat insertion binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Direct protein-DNA complex formation | Testing binding to dinucleotide repeat substrates |
| ChIP-seq | Genomic occupancy of repeat-binding proteins | Mapping binding sites in repeat-rich regions |
| CRISPR knock-in reporter | Binding and repair at defined repeats [1,5] | Causal testing of candidate proteins |
| Mismatch repair assay | Functional repair of dinucleotide loops | Comparing MutSbeta and MutSalpha activity |
| Western blot | Protein expression and complex integrity | Validating knockout or overexpression |
| Co-immunoprecipitation | Protein-protein interactions in repair complexes | Identifying partners of repeat-binding proteins |
| DNA sequencing | Repeat length and stability [1,8] | Monitoring microsatellite instability |
| CRISPR screen | Genes required for repeat processing | Identifying WRN dependence and modifiers |
Electrophoretic mobility shift assays (EMSA)
EMSA with defined dinucleotide repeat-containing DNA substrates can detect direct binding by candidate proteins such as MutSbeta. This method measures the formation of protein-DNA complexes and can be used to compare binding affinities between wild-type and mutant proteins.
Chromatin immunoprecipitation (ChIP)
ChIP followed by sequencing can map proteins to repeat-containing genomic regions and assess whether dinucleotide repeat insertion binding occurs in a chromatin context. This approach is useful for validating binding sites identified by other methods.
CRISPR-engineered repeat reporters
CRISPR knock-in of defined dinucleotide repeats into reporter loci allows controlled measurement of binding and downstream repair outcomes [1,5]. Such models can be combined with knockout of candidate binders to test causality.
Functional repair assays
Mismatch repair assays using dinucleotide loop substrates can quantify the functional consequence of dinucleotide repeat insertion binding. These assays help distinguish binding from downstream repair activity.
How CRISPR Can Be Used to Study GO:0032181 dinucleotide repeat insertion binding
Knockout
CRISPR knockout of candidate genes such as MSH3 or MSH2 can test whether loss of the protein abolishes dinucleotide repeat insertion binding and alters repeat stability. Knockout models are essential for establishing causality in mismatch repair pathways.
Point Mutation
Point-mutation knock-in can dissect specific residues required for recognition of dinucleotide loops, allowing separation of binding from other functions. Such models are useful for studying missense variants found in cancer.
Knock-in
Knock-in of tagged or reporter alleles enables visualization and mapping of dinucleotide repeat insertion binding in a native genomic context [1,5]. Repeat knock-in models can also recreate disease-relevant expansions.
Overexpression
Overexpression of a candidate repeat-binding protein can test whether increased levels destabilize repeats or alter repair outcomes. This approach complements loss-of-function studies.
How EDITGENE Supports dinucleotide repeat insertion binding Research
Researchers studying dinucleotide repeat insertion binding-related genes often need to determine whether a candidate gene is causally involved in repeat recognition, repair, or disease progression. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in, and overexpression of these genes in relevant cellular backgrounds.
Contact EDITGENE today to design your custom CRISPR model for dinucleotide repeat insertion binding research.
Frequently Asked Questions About dinucleotide repeat insertion binding
What is GO:0032181 dinucleotide repeat insertion binding?
It is a molecular function term describing binding to double-stranded DNA containing a dinucleotide repeat insertion or unpaired dinucleotide repeats.
What genes are involved in dinucleotide repeat insertion binding?
Key genes include MSH2, MSH3, MSH6, WRN, and CNBP, based on their roles in repeat recognition and repair [1,5,8].
Which protein complex binds dinucleotide loops?
MutSbeta, a heterodimer of MSH2 and MSH3, binds dinucleotide loops and exceeds MutSalpha in dinucleotide loop repair.
How is dinucleotide repeat insertion binding measured?
Common methods include EMSA, ChIP-seq, and functional mismatch repair assays with defined repeat substrates.
Why is dinucleotide repeat insertion binding important in cancer?
It is linked to microsatellite instability, and repeat expansions can confer WRN dependence in microsatellite-unstable cancers [1,5].
What diseases are associated with dinucleotide repeat instability?
Microsatellite-unstable cancers and myotonic dystrophy type 2 are associated with dinucleotide repeat instability [1,5,8].
Can CRISPR be used to study dinucleotide repeat insertion binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the function of candidate repeat-binding proteins [1,5].
What is the substrate of GO:0032181?
The substrate is double-stranded DNA containing a dinucleotide repeat insertion or a deletion resulting in unpaired dinucleotide repeats.
How does MutSbeta differ from MutSalpha?
MutSbeta exceeds MutSalpha in dinucleotide loop repair, indicating a specialized role in dinucleotide repeat recognition.
What is the link between CCTG repeats and myotonic dystrophy type 2?
The unstable CCTG repeat responsible for myotonic dystrophy type 2 originated from an AluSx element insertion into an early primate genome.
Conclusion
GO:0032181 dinucleotide repeat insertion binding defines a specific DNA-binding function that is central to the recognition of unpaired dinucleotide repeats. MutSbeta is a key binder, and its activity exceeds that of MutSalpha in dinucleotide loop repair, linking this function to microsatellite instability and cancer. Repeat expansion disorders such as myotonic dystrophy type 2 further illustrate how insertion events can create pathogenic repeats. Recent findings that repeat expansions confer WRN dependence in microsatellite-unstable cancers highlight the therapeutic relevance of this pathway. Continued research using CRISPR-engineered models and binding assays will clarify how dinucleotide repeat insertion binding is regulated and how it can be targeted in disease [1,5].
References
- 1. van Wietmarschen N et al.. 2020. Repeat expansions confer WRN dependence in microsatellite-unstable cancers.. Nature 586(7828):292-298 PMID: 32999459
- 2. Rosenbloom J et al.. 1995. Structure of the elastin gene.. Ciba Found Symp 192:59-74; discussion 74-80 PMID: 8575268
- 3. Dang PM et al.. 2000. Binding of nicotinamide adenine dinucleotide phosphate to the tetratricopeptide repeat domains at the N-terminus of p67PHOX, a subunit of the leukocyte nicotinamide adenine dinucleotide phosphate oxidase.. Biochemistry 39(11):3069-75 PMID: 10715128
- 4. Pflieger A et al.. 2014. Target capture during Mos1 transposition.. J Biol Chem 289(1):100-11 PMID: 24269942
- 5. Kantelinen J et al.. 2010. MutSbeta exceeds MutSalpha in dinucleotide loop repair.. Br J Cancer 102(6):1068-73 PMID: 20160730
- 6. Hackett PB et al.. 2005. Sleeping beauty transposon-mediated gene therapy for prolonged expression.. Adv Genet 54:189-232 PMID: 16096013
- 7. Patel DJ et al.. 1981. Right-handed alternating DNA conformation: poly(dA-dT) adopts the same dinucleotide repeat with cesium, tetraalkylammonium, and 3 alpha, 5 beta, 17 beta-dipyrrolidinium steroid dimethiodide cations in aqueous solution.. Proc Natl Acad Sci U S A 78(7):4063-7 PMID: 6945570
- 8. Kurosaki T et al.. 2012. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.. PLoS One 7(6):e38379 PMID: 22723857
